Back to Results

NAtalizumab for Prevention of Post-partum Relapses in patients with Multiple Sclerosis 09May2016

Primary Objective

To assess the efficacy of IV administered natalizumab, monthly for 1 year, in preventing relapses during the postpartum period.

Study category: Brain and Nervous System

Is this Study for You?

Let's Get Started!




IV - Research Studies occurring after FDA has approved a drug for marketing. These studies gather additional information about a drug's safety, efficacy, or optimal use.

Type of Study



University of Colorado Hospital

Principal Investigator
Teri Schreiner

Teri Schreiner

Study ID

Protocol Number: 16-0156

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers